Michael is a Clinical Trial Project Manager for the NN107 and NN108 studies. In this role, he manages study communications, regulatory submissions, and study team coordination on various project needs. He is also responsible for writing, reviewing, and overseeing cIRB and DSMB submissions as well as study amendments, site invoices, and annual continuing reviews.
Email: